F40 F41
Conditions
Interventions
Group 1: The first arm of the study comprises the intervention group, which consists of participants with self-reported anxiety (see: Disease/health problem under investigation). The intervention grou
Sponsors
Universitätsklinikum Hamburg-Eppendorf
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: a) presence of anxiety symptoms, b) age of 18-75 years, c) informed consent to participate in the study, d) sufficient command of German, e) willingness to participate in three anonymous online surveys, f) willingness to use the app independently
Exclusion criteria
Exclusion criteria: a) bipolar or psychotic disorder, b) acute suicidal tendencies
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The Generalized Anxiety Disorder Scale 7 (GAD-7) is used as the primary outcome to measure changes in anxiety symptoms at the beginning of the study (baseline survey), after six weeks of using the app (post-intervention survey) and after a further three months (follow-up survey). | — |
Secondary
| Measure | Time frame |
|---|---|
| - reduction of depressive symptoms, measured with the Patient Health Questionnaire (PHQ-9) - improvement in quality of life, measured with the global item of the World Health Organization Quality of Life Scale - Brief Version (WHOQOL-Bref) - improvement in self-esteem, measured with the Rosenberg Self-Esteem Scale (RSE) - subjective satisfaction with the app, measured using the Questionnaire for Measuring Patient Satisfaction (ZUF-8) The measurements are assessed at the beginning of the study (baseline survey), after six weeks of using the app (post-intervention survey) and after a further three months (follow-up survey). | — |
Countries
Austria, Germany, Switzerland
Contacts
Public ContactSteffen Moritz
Universitätsklinikum Hamburg-Eppendorf
Outcome results
None listed